Article
Inflammatory phenotyping predicts clinical outcome in COVID-19.
Respiratory research - 22 Sept 2020
Burke H, Freeman A, Cellura D C, Stuart B L, Brendish N J, Poole S, Borca F, Phan H T T, Sheard N, Williams S, Spalluto C M, Staples K J, Clark T W, Wilkinson T M A
Abstract excerpt
BACKGROUND: The COVID-19 pandemic has led to more than 760,000 deaths worldwide (correct as of 16th August 2020). Studies suggest a hyperinflammatory response is a major cause of disease severity and death. Identitfying COVID-19 patients with hyperinflammation may identify subgroups who could benefit from targeted immunomodulatory treatments. Analysis of cytokine levels at the point of diagnosis of SARS-CoV-2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
